What has women's reproductive health decision-making capacity and other factors got to do with pregnancy termination in sub-Saharan Africa? evidence from 27 cross-sectional surveys.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 13 11 2019
accepted: 14 06 2020
entrez: 24 7 2020
pubmed: 24 7 2020
medline: 10 9 2020
Statut: epublish

Résumé

Pregnancy termination is one of the key issues that require urgent attention in achieving the third Sustainable Development Goal (SDG) of ensuring healthy lives and promoting well-being for all at all ages. The reproductive health decision-making (RHDM) capacity of women plays a key role in their reproductive health outcomes, including pregnancy termination. Based on this premise, we examined RHDM capacity and pregnancy termination among women of reproductive age in sub-Saharan Africa (SSA). We pooled data from the women's files of the most recent Demographic and Health Surveys (DHS) of 27 countries in SSA, which are part of the DHS programme. The total sample was 240,489 women aged 15 to 49. We calculated the overall prevalence of pregnancy termination in the 27 countries as well as the prevalence in each individual country. We also examined the association between RHDM capacity, socio-demographic characteristics and pregnancy termination. RHDM was generated from two variables: decision-making on sexual intercourse and decision-making on condom use. Binary logistic regression analysis was conducted and presented as Crude Odds Ratios (COR) and Adjusted Odds Ratios (AOR) with their corresponding 95% confidence intervals (CI). Statistical significance was declared p<0.05. The prevalence of pregnancy termination ranged from 7.5% in Benin to 39.5% in Gabon with an average of 16.5%. Women who were capable of taking reproductive health decisions had higher odds of terminating a pregnancy than those who were incapable (AOR = 1.20, 95% CI = 1.17-1.24). We also found that women aged 45-49 (AOR = 5.54, 95% CI = 5.11-6.01), women with primary level of education (AOR = 1.14, 95% CI = 1.20-1.17), those cohabiting (AOR = 1.08, 95% CI = 1.04-1.11), those in the richest wealth quintile (AOR = 1.06, 95% CI = 1.02-1.11) and women employed in the services sector (AOR = 1.35, 95% CI = 1.27-1.44) were more likely to terminate pregnancies. Relatedly, women who did not intend to use contraceptive (AOR = 1.47, 95% CI = 1.39-1.56), those who knew only folkloric contraceptive method (AOR = 1.25, 95% CI = 1.18-1.32), women who watched television almost every day (AOR = 1.16, 95% CI = 1.20-1.24) and those who listened to radio almost every day (AOR = 1.11, 95% CI = 1.04-1.18) had higher odds of terminating a pregnancy. However, women with four or more children had the lowest odds (AOR = 0.5, 95% CI = 0.54-0.60) of terminating a pregnancy. We found that women who are capable of taking reproductive health decisions are more likely to terminate pregnancies. Our findings also suggest that age, level of education, contraceptive use and intention, place of residence, and parity are associated with pregnancy termination. Our findings call for the implementation of policies or the strengthening of existing ones to empower women about RHDM capacity. Such empowerment could have a positive impact on their uptake of safe abortions. Achieving this will not only accelerate progress towards the achievement of maternal health-related SDGs but would also immensely reduce the number of women who die as a result of pregnancy termination in SSA.

Identifiants

pubmed: 32702035
doi: 10.1371/journal.pone.0235329
pii: PONE-D-19-30083
pmc: PMC7377410
doi:

Substances chimiques

Contraceptive Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0235329

Déclaration de conflit d'intérêts

The authors have declared that no competing interest exist.

Références

Afr J Reprod Health. 2010 Dec;14(4 Spec no.):110-6
pubmed: 21812204
PLoS One. 2019 Aug 9;14(8):e0220970
pubmed: 31398240
Am J Epidemiol. 2015 Oct 15;182(8):663-9
pubmed: 26377957
Bull World Health Organ. 2018 Sep 1;96(9):644-653
pubmed: 30262946
Arch Public Health. 2018 Jul 19;76:37
pubmed: 30034803
Int Perspect Sex Reprod Health. 2012 Mar;38(1):23-33
pubmed: 22481146
AIDS Care. 2018 Feb;30(2):240-245
pubmed: 28783967
BMC Womens Health. 2015;15:17
pubmed: 25783648
Popul Stud (Camb). 2015;69(3):373-88
pubmed: 26449684
Open Access J Contracept. 2018 Jul 16;9:45-55
pubmed: 30038527
BMC Int Health Hum Rights. 2011 Dec 16;11 Suppl 3:S8
pubmed: 22376197
Syst Rev. 2018 Aug 25;7(1):130
pubmed: 30144826
Arch Public Health. 2018 Jan 29;76:5
pubmed: 29423218
BMC Public Health. 2015 Feb 12;15:139
pubmed: 25886459
Lancet. 2017 Nov 25;390(10110):2372-2381
pubmed: 28964589
J Pregnancy. 2019 Jan 30;2019:2920491
pubmed: 30834145
Afr J Reprod Health. 2014 Sep;18(3):17-35
pubmed: 25438507
Clin Obstet Gynecol. 2009 Jun;52(2):205-12
pubmed: 19407527
BMC Public Health. 2015 Feb 28;15:202
pubmed: 25885483
Afr J Reprod Health. 2016 Sep;20(3):22-25
pubmed: 29553188
BMC Pregnancy Childbirth. 2017 Nov 8;17(Suppl 2):352
pubmed: 29143677
Int Perspect Sex Reprod Health. 2014 Sep;40(3):119-26
pubmed: 25271647
BMJ Glob Health. 2018 Apr 27;3(2):e000707
pubmed: 29713502
PLoS One. 2017 Mar 29;12(3):e0172976
pubmed: 28355285
PLoS One. 2019 Jan 9;14(1):e0209985
pubmed: 30625212
Reprod Health. 2014 Mar 15;11:23
pubmed: 24628727
Int Perspect Sex Reprod Health. 2012 Jun;38(2):78-89
pubmed: 22832148
Obstet Gynecol. 2018 Mar;131(3):457-463
pubmed: 29420406
BMC Pregnancy Childbirth. 2018 Sep 17;18(1):376
pubmed: 30223798
Int J Environ Res Public Health. 2018 Feb 13;15(2):
pubmed: 29438335
BMC Pregnancy Childbirth. 2019 Mar 13;19(1):92
pubmed: 30866838
Lancet. 2006 Nov 25;368(9550):1908-19
pubmed: 17126724
Health Policy Plan. 2010 Jul;25(4):300-10
pubmed: 20008904
PLoS One. 2017 Oct 17;12(10):e0186287
pubmed: 29040334
Health Care Women Int. 2007 Jul;28(6):534-55
pubmed: 17578714
Open Nurs J. 2009 Aug 06;3:33-8
pubmed: 19707520
Health Hum Rights. 2013 Jun 14;15(1):E161-74
pubmed: 25006084
Hum Reprod. 2000 Nov;15(11):2433-7
pubmed: 11056148
Reprod Health. 2010 Jul 15;7:15
pubmed: 20630107
Int J Womens Health. 2014 Aug 21;6:809-16
pubmed: 25187740
Lancet. 2014 Aug 2;384(9941):e30-1
pubmed: 25043387
Int J Epidemiol. 2012 Dec;41(6):1602-13
pubmed: 23148108
J Pregnancy. 2019 Feb 3;2019:9253650
pubmed: 30854238
Curr Opin Obstet Gynecol. 2018 Dec;30(6):337-343
pubmed: 30239372

Auteurs

Abdul-Aziz Seidu (AA)

Department of Population and Health, University of Cape Coast, Cape Coast, Ghana.
College of Public Health, Medical and Veterinary Sciences, James Cook University, Townsville, Queensland, Australia.

Bright Opoku Ahinkorah (BO)

The Australian Centre for Public and Population Health Research (ACPPHR), Faculty of Health, University of Technology Sydney, Sydney, Australia.

Edward Kwabena Ameyaw (EK)

The Australian Centre for Public and Population Health Research (ACPPHR), Faculty of Health, University of Technology Sydney, Sydney, Australia.

Amu Hubert (A)

Department of Population and Health, University of Cape Coast, Cape Coast, Ghana.
Department of Population and Behavioural Sciences, School of Public Health, University of Health and Allied Sciences, Hohoe, Ghana.

Wonder Agbemavi (W)

Department of Population and Health, University of Cape Coast, Cape Coast, Ghana.

Ebenezer Kwesi Armah-Ansah (EK)

Department of Population and Health, University of Cape Coast, Cape Coast, Ghana.

Eugene Budu (E)

Department of Population and Health, University of Cape Coast, Cape Coast, Ghana.

Francis Sambah (F)

Department of Health, Physical Education and Recreation, University of Cape Coast, Cape Coast, Ghana.

Vivian Tackie (V)

Department of Health, Physical Education and Recreation, University of Cape Coast, Cape Coast, Ghana.
Department of Public Health, School of Nursing and Midwifery, University of Health and Allied Sciences, Ho, Ghana.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH